SCHEMBL154381

SCHEMBL154381

CN[C@H](CCC(N)=O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
ALOX15 P16050 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
CA2 P00918 5/20 0.43
CA1 P00915 4/20 0.43
FOLH1 Q04609 5/20 0.42
RIMKLA Q8IXN7 1/20 0.42
NAALAD2 Q9Y3Q0 1/20 0.42
BMP1 P13497 1/20 0.42
GGH Q92820 1/20 0.40
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8139 1.00 KMT2A (0.50) KMT2AALOX15BLMPMP22MMP2
SCHEMBL8140 1.00 KMT2A (0.50) KMT2AALOX15BLMPMP22MMP2
Hydrochloric Acid SCHEMBL22978412 0.98 KMT2A (0.48) KMT2AALOX15BLMPMP22MMP2
SCHEMBL30423570 0.98 KMT2A (0.48) KMT2AALOX15BLMPMP22MMP2
Hydrochloric Acid SCHEMBL5408064 0.98 KMT2A (0.48) KMT2AALOX15BLMPMP22MMP2
Hydrochloric Acid SCHEMBL23834101 0.98 KMT2A (0.48) KMT2AALOX15BLMPMP22MMP2
SCHEMBL12611816 0.94 FOLH1 (0.52) KMT2AALOX15BLMPMP22MMP2
SCHEMBL12611809 0.94 FOLH1 (0.52) KMT2AALOX15BLMPMP22MMP2
Phosphoric Acid SCHEMBL8519191 0.92 GGH (0.47) KMT2AALOX15BLMPMP22MMP2
Phosphoric Acid SCHEMBL8519199 0.92 GGH (0.47) KMT2AALOX15BLMPMP22MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2439 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240301023-A1 PEPTIDES AND USES THEREOF PreveCeutical Medical Inc. (CA) 2024-09-12 US claimed
EP-4175970-A1 PEPTIDES AND USES THEREOF Preveceutical Medical Inc. (CA) 2023-05-10 EP claimed
WO-2022000043-A1 PEPTIDES AND USES THEREOF PreveCeutical Medical Inc. (CA) 2022-01-06 WO claimed
US-9695191-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2017-07-04 US claimed
US-20160289108-A1 PROCESS FOR TREATMENT OF PRODUCTION WATER USING POLYOLS WATER WATER INC (US) 2016-10-06 US claimed
CN-105287241-A Mascara composition comprising soap-base and manufacturing method thereof COSMAX INC 2016-02-03 CN claimed
EP-2462147-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2014-11-12 EP claimed
US-20120202821-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-08-09 US claimed
US-20090215895-A1 Therapeutic and carrier molecules PEPLIN BIOLIPIDS PTY LTD (AU) 2009-08-27 US claimed
US-7256172-B1 Method of treatment and agents useful for same THE UNIVERSITY OF MELBOURNE (AU) 2007-08-14 US claimed
EP-1404678-B1 WATER-SOLUBLE PORPHYRIN DERIVATIVES FOR PHOTODYNAMIC THERAPY, THEIR USE AND MANUFACTURE CERAMOPTEC GMBH (DE) 2006-08-16 EP claimed
US-20260140060-A1 COLORIMETRIC DETECTION OF A VIRAL INFECTION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2026-05-21 US disclosed
US-20260124281-A1 FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE ENTERA BIO LTD. (IL) 2026-05-07 US disclosed
WO-2026085582-A1 PROTEIN CAGES THE UNIVERSITY OF SYDNEY (AU) 2026-04-30 WO disclosed
EP-4731266-A1 NANOPARTICLE COMPOSITIONS ASSOCIATED WITH PEPTIDES The Regents of the University of Michigan (US) 2026-04-29 EP disclosed
US-4916246-A Paramagnetic chelates useful for NMR imaging BRACCO CHIMICA S.P.A. (IT) 1990-04-10 US disclosed
US-4581458-A 5-substituted-3-aminoisoxazole compounds WARNER-LAMBERT COMPANY (US) 1986-04-08 US disclosed
US-4489077-A 3-Isoxa-zolyl-2H-1,2-benzothiazine-3-carboxamide, 1,1-dioxides WARNER-LAMBERT COMPANY (US) 1984-12-18 US disclosed
EP-0123418-A1 4-Hydroxy-N-(5((substituted hetero) methyl)-3-isoxazolyl-2H-1,2-benzothiazine-3-carboxamide,1,1-dioxide and 4-hydroxy-2-alkyl-N-(5-((substituted hetero) methyl)-3-isoxazolyl)2H-1,2-benzothiazine-3-carboxamide,1,1-dioxide WARNER-LAMBERT COMPANY (US) 1984-10-31 EP disclosed
US-4423244-A Process for the preparation of the d-2-(6-methoxy-2-naphthyl)-propionic acid ALFA CHEMICALS ITALIANA S.P.A. (IT) 1983-12-27 US disclosed